Objectives: To determine the stability/reversibility and mechanism of monensin adaptation in monensintreated cattle isolates compared with reference bacterial isolates, exposed in vitro to high monensin concentrations.
Introduction
Ionophore antibiotics are a group of natural fermentation products produced by actinomycetes that are so named because they bind cations such as K + , Na + , Ca 2+ and Mg 2+ . The ionophore group of antibiotics may be divided into three separate classes: neutral ionophores, channel-forming quasi-ionophores and carboxylic, or polyether, ionophores. The carboxylic ionophore antibiotics may be further differentiated into two subclasses according to cation-binding preferences. Monovalent carboxylic ionophores preferentially bind K + and Na + while divalent carboxylic ionophores preferentially bind Ca 2+ and Mg 2+ . Monensin is a monovalent carboxylic ionophore that is produced by Streptomyces cinnamonensis.
1
Monensin exerts its antibacterial effects using a mode of action that is very different from that of other antibiotics. Most antibiotics work by binding to an enzyme, ribosome, lipid or cell wall target, which results in a cessation of essential cellular processes. In contrast, monensin inserts itself into the cell membrane and interferes with the maintenance of important ion gradients in the cell, which are needed for the transport of nutrients and to generate proton-motive force. 2 -4 Normally, ruminal bacteria maintain high intracellular K + (potassium) concentrations, low intracellular Na + (sodium) concentrations and H + (hydrogen)
concentrations that are sufficient to maintain a neutral intracellular pH in the presence of the acidic ruminal environment, which contains low concentrations of K + and high concentrations of Na + . Once monensin is inserted into the membrane, it acts as a metal/proton anti-porter: K + is exported from the cell while H + is simultaneously imported into the cell and H + is exported from the cell while Na + is simultaneously imported into the cell. The K + gradient is much larger than the Na + gradient and high concentrations of protons enter the cell and acidify the cytoplasm. The cell responds to the ion imbalances by recruiting the reversible ATPase/ATP synthase to export the H + from the cell and by activating pumps that utilize ATP to export Na + from the cell and to import K + into the cell. In attempting to restore a normal ion gradient, the cell diverts its ATP away from other important cellular functions and growth ceases. 2 -4 Generally speaking, Gram-positive bacteria are more susceptible to monensin than Gram-negative bacteria. 1, 3 The intrinsic resistance of Gram-negative bacteria to monensin is attributed to the decreased permeability through the lipopolysaccharide layer, the outer membrane and periplasmic space in order to insert into the cell membrane. 2 -5 It is well established that the level of feed intake in dairy cows during early lactation is often insufficient to support high milk production, thus resulting in an increase in the incidence of metabolic disease seen during the transition from the dry period to full lactation. The inability to increase dry matter intake quickly enough to meet these needs results in a negative energy balance between the physiological demand for lactation energy and available dietary energy. 6 This may lead to ketone formation, which can be used for energy supply by various tissues. However, if production exceeds use, they may accumulate. While this is a normal physiological response to the increased nutritional demands of early lactation and the insufficient supply of glucose precursors, 7 the increased ketone levels (hyperketonaemia) may also present a drawback to animal performance, and may predispose the cow to metabolic imbalances and periparturient diseases, including ketosis. Recent evidence determined that the critical threshold for predicting ketosis, displaced abomasums and metritis was a b-hydroxybutyrate (BHB) concentration of 10 mg/dL.
8 Both pre-and post-partum BHB concentrations above this critical threshold were associated with an increased risk of subsequent disease.
Monensin exerts its effects by altering the microbial populations in the rumen, 9 resulting in a shift in the ratio of volatile fatty acids, increasing propionic acid and reducing the molar proportions of butyric and acetic acids. 6, 10 This anti-ketogenic effect has previously been demonstrated in field studies. 11 As a result, a controlled release capsule has been used in Canada and Australia to allow a long-term release of monensin in order to maintain the desired microbial population balance in the rumen, which maintains the appropriate acid balance to prevent ketosis and related disorders in dairy cattle. 6, 12 Monensin is also approved for use in medicated feed in lactating dairy cattle for increased milk production in the USA. 13 The use of antibiotics will introduce selective pressure that may ultimately lead to the development of antibiotic resistance. Zoonotic organisms are transferred from animals to humans, and the transfer of commensal bacteria from animals to humans via the food chain is also possible. Food animals therefore represent a potential reservoir of antibiotic-resistant microorganisms and the food chain thus represents a route of transmission of e.g. resistant bacteria and/or resistance genes from animals to humans. As mentioned, most Gram-negative bacteria can be considered intrinsically resistant; thus, resistance development in Escherichia coli, Salmonella spp. and Campylobacter spp. in the presence of monensin in animals is not an issue. Enterococcus spp. are susceptible to monensin, but, despite .35years of use, monensin-resistant strains of these bacteria have not been isolated from animals. 14 -19 The fact that monensin-resistant foodborne bacteria have not been isolated from food animals suggests that monensin use does not select for such strains.
However, monensin adaptation has been described in rumen bacteria. In this case, in vitro cultures of rumen bacteria have demonstrated a long lag phase prior to growth in the presence of monensin. If the same culture is passaged again in antibioticcontaining medium, then the initial lag phase disappears and the cultures are said to be adapted. Adapted cultures can subsequently be shown to grow in even higher concentrations of monensin. 20 -25 The present study was conducted to better understand the mechanism responsible for monensin adaptation in Enterococcus faecium, Enterococcus faecalis and Clostridium perfringens recovered from cattle and the potential for impact on human food safety.
Materials and methods

Strain selection
One isolate each of E. faecium (strain DWC18720), E. faecalis (strain DWC18721) and C. perfringens (strain DWC18718) of cattle origin and previously exposed to monensin in vivo at a dose of 670 mg/day for 42 (C. perfringens) or 91 (E. faecium and E. faecalis) continuous days were selected. These three isolates were isolated using standard laboratory isolation methods and were referred to as 'monensin-exposed isolates'. In addition, three monensin non-exposed strains, E. faecium (strain ATCC 19434), E. faecalis (strain ATCC 29212) and C. perfringens (ATCC 13124), were also selected for the present study. ATCC isolates were selected as they represented isolates known not to have previously been exposed to monensin.
MIC determination
All monensin MICs were determined using the agar dilution method in accordance with CLSI guidelines M7-A8
26 (E. faecium and E. faecalis) and M11-A7 27 (C. perfringens). The following isolates served as quality control isolates: Bacteroides fragilis (ATCC 25285), Eubacterium lentum (ATCC 43055), E. faecalis (ATCC 29212) and Staphylococcus aureus (ATCC 29213); these are discussed in the Results section.
Mutation frequency studies
To produce an inoculum for determination of mutation frequency, the C. perfringens strains were incubated anaerobically in 120 mL of Wilkins -Chalgren anaerobe broth and the Enterococcus strains were incubated aerobically in 120 mL of Mueller-Hinton broth. Each incubated culture was centrifuged and the cell pellet was resuspended in 8 mL of the original culture medium to produce a dense suspension. Volumes of 1.0 mL of this dense suspension were used to inoculate 90 mm Petri dishes containing monensin concentrations between 2× MIC and 32× MIC. Duplicate Petri dishes were inoculated for each concentration so that an inoculum of 5×10 9 cfu per Petri dish was achieved when
Monensin adaptation in enterococci and clostridia inoculated with 1.0 mL of the dense suspension. Inoculated Petri dishes were incubated for 48 h and the colonies on each plate were enumerated. All isolates were stored at 2808C until further analysis. Any strain that showed growth at more than 4× MIC was considered a monensin-adapted strain. For each monensin-adapted strain, bacterial cells were sampled directly from the highest plate that supported growth and 21 consecutive 24 h subcultures were performed on monensin-free agar. The MIC of monensin for the 3rd, 7th, 14th and 21st subcultures of each monensin-adapted strain was determined as described above. The strains were classified as 'subcultured isolates' and stored at 2808C until further analysis.
SDS -PAGE
Monensin-exposed strains (E. faecium strain DWC18720, E. faecalis strain DWC18721 and C. perfringens strain DWC18718) along with the corresponding monensin-adapted strains (strains from the mutation frequency study that grew at 32× MIC) and the subcultured isolates were harvested for SDS-PAGE analysis as previously described. 28 
Transmission electron microscopy (TEM)
TEM was employed to examine the cell morphology (especially cell wall structure) of E. faecium strain DWC18720, E. faecalis strain DWC18721 and C. perfringens strain DWC18718 before and after exposure to monensin at concentrations above the previously determined MIC. For each strain, in vivo monensin-exposed isolates, in vitro monensin-adapted isolates and subcultured isolates that had stable monensin MICs were used in the TEM study. TEM was carried out using standard methodology that included fixation, dehydration, embedding, sectioning and staining of sections. 29 Stained sections were viewed in the TEM at high magnification such that the cell walls and any extracellular polysaccharide were clearly visible. Digital photomicrographs of sections at right angles to the cell walls of each culture were recorded.
Results
MIC determination
The initial monensin MIC for all six isolates used in this study [E. faecium (strain DWC18720), E. faecalis (strain DWC18721), C. perfringens (DWC18718), E. faecium (strain ATCC 19434), E. faecalis (strain ATCC 29212) and C. perfringens (ATCC 13124)] was 4 mg/L (Table 1) .
Although currently there are no defined anaerobic CLSI quality control isolates for monensin, the two anaerobic isolates used in the present study consistently performed within a narrow range (B. fragilis ATCC 25285, monensin MIC range 128-512 mg/L; and E. lentum ATCC 43055, monensin MIC range 1-2 mg/L) and the two aerobic isolates were consistently within CLSI-defined ranges (E. faecalis ATCC 29212, monensin MIC range 4 -8 mg/L; and S. aureus ATCC 29213, monensin MIC 4 mg/L).
Mutation frequency studies
For the monensin-naive bacterial strains C. perfringens ATCC 13124, E. faecium ATCC 19434 and E. faecalis ATCC 29212, growth only occurred up to 2× the original MIC, which suggests that the bacteria were effectively inhibited. The mutation frequency experiments demonstrated that the in vivo monensin-exposed strains were able to grow, albeit as small colonies, to densities that could not be enumerated, whereas the monensin-naive ATCC strains were not able to do so.
For the in vivo monensin-exposed strains C. perfringens DWC 18718, E. faecium DWC 18720 and E. faecalis DWC 18721, growth was observed up to 32× the original MIC. Confluent growth was observed on all plates; therefore, a precise mutation frequency could not be calculated. These isolates were subsequently reclassified as in vitro monensin-adapted isolates. For each in vitro monensin-adapted strain, bacterial cells were sampled directly from the highest plate that supported growth and 21 consecutive 24 h subcultures were then performed. The MIC of monensin for the 3rd, 7th, 14th and 21st subcultures of each in vitro monensin-adapted strain was determined to assess the stability of this apparent phenotypic adaptation.
C. perfringens DWC 18718 grew in the presence of monensin concentrations up to 32× the original MIC. The MIC of monensin for the original in vivo monensin-exposed strain was 4 mg/L and for a third passage subculture isolate it was 8 mg/L. The MIC for the seventh passage subculture isolate returned to the original MIC of 4 mg/L (Table 1) .
Both E. faecium DWC 18720 and E. faecalis DWC 18721 grew in the presence of monensin concentrations up to 32× the original MIC. The MIC of monensin for the original in vivo monensin-exposed strains was 4 mg/L. For the third passage subculture of both of these strains the MIC was 16 mg/L. The MICs for the 7th, 14th and 21st passage subcultures of E. faecium DWC 18720 were 8 mg/L, within one doubling dilution of the original MIC of 4 mg/L. The MIC for the seventh passage subculture of E. faecalis DWC 18721 returned to the original MIC of 4 mg/L (Table 1) . Simjee et al. Monensin adaptation in enterococci and clostridia 2391 JAC
SDS -PAGE
To further characterize the phenotypic monensin adaptation observed in the mutation frequency study described above, SDS-PAGE analysis to examine the protein composition of Enterococcus and Clostridium strains with regard to cell structure of the monensin-naive (E. faecium ATCC 19434, E. faecalis ATCC 29212 and C. perfringens ATCC 13124), in vitro monensinadapted and subcultured isolates, showing baseline MICs, was undertaken.
For each of the three bacterial species (C. perfringens DWC 18718, E. faecalis DWC 18721 and E. faecium DWC 18720), SDS-PAGE profiles of cultures analysed directly after growth in the presence of monensin at 32× MIC exhibited differences in comparison with both monensin-naive cultures and the subcultured strains with stable MICs. These differences are described below and shown in Figure 1 .
In the 32× MIC culture of C. perfringens DWC 18718, four protein bands were of a markedly lower intensity than the corresponding bands produced by the non-exposed or subcultured isolates, although the intensity of protein bands was generally lower than those obtained from the non-exposed or subcultured isolates. Additionally, in the 32× MIC culture, there was a single protein band of a markedly higher intensity than the corresponding band produced by the non-exposed or subcultured strains. This band was calculated to be of molecular size 14 kDa (Figure 1 ).
In the 32× MIC cultures of E. faecalis DWC 18721 and E. faecium DWC 18720, although the protein bands were generally of lower intensity than those obtained from the non-exposed and subculture isolates, one band showed a markedly higher intensity than the corresponding band produced by the non-exposed or subcultured isolates. This band was calculated to be of molecular size 20.5 kDa (Figure 1 ).
No differences in SDS-PAGE profile were detected between non-exposed isolates and the repeatedly subcultured isolates with stable MICs, i.e. MICs similar to the monensin-naive isolates, indicating that the change was transient.
TEM
TEM was employed to examine the cell morphology (especially cell wall structure) of in vivo monensin-exposed, in vitro monensin-adapted and subcultured isolates of C. perfringens, E. faecium and E. faecalis.
To ensure that the monensin-adapted isolates, stored at 2808C, expressed high MICs at the point of TEM examination, each strain was tested for monensin susceptibility. The MIC data showed that the stored strains had reverted to baseline MICs. This indicates that the adaptation of the 32× MIC strains to monensin was temporary. Consequently, mutation frequency studies were repeated as described above and fresh isolates of C. perfringens, E. faecalis and E. faecium growing at 32× MIC were harvested. The isolates harvested at 32× MIC were either used to confirm the MICs (which were confirmed as .32× MIC) or were subjected to chemical fixation prior to TEM examination.
For all three bacterial strains, the TEM photographs showed that there was a temporary alteration in the thickness of the bacterial cell wall or glycocalyx when the bacterial strain was exposed to 32× the original MIC of monensin. There was a clear increase in the width of the cell wall or glycocalyx, which was visible at both ×49 000 and ×9300 magnification. As an example the E. faecium TEM photographs are shown in Simjee et al. 
Discussion
It is postulated that the temporary increase in MIC values observed following monensin exposure were not the result of true genetic mutations that result in transferable or heritable resistance. Since monensin MICs returned to baseline levels or near baseline levels after passaging of the phenotypically adapted isolates post-monensin exposure, the elevated MICs are more likely to be attributable to a transient adaptation of the isolates to the experimental monensin exposure. The potential mechanism of this temporary adaptation was further examined by SDS-PAGE analysis.
The SDS -PAGE analysis suggests that, in response to high concentrations of monensin, C. perfringens, E. faecium and E. faecalis previously exposed to monensin in vivo produce an additional protein.
Although the actual function of this protein is unknown, it can be assumed that it is responsible for the phenotypic adaptation towards monensin that was observed in the mutation frequency studies. To further ascertain whether this phenotypic adaptation was a consequence of structural changes in the bacterial cell, such as cell wall thickening, which would result in reduced monensin insertion, TEM studies were undertaken to evaluate whether changes to the bacterial cell structure occurred in the presence of high concentrations of monensin. The increase in cell wall or glycocalyx thickness due to exposure to monensin at 32× MIC was determined to be transient by TEM studies, as reversion to the non-exposed cell wall or glycocalyx state was observed for strains that were exposed to monensin and then repeatedly subcultured, as seen in Figure 2 .
The data from the three studies described in detail above confirm that monensin adaptation, at least in the three bacterial species examined, is only observed in bacteria previously exposed in vivo to monensin. However, this is a transient occurrence as a result of cell wall or glycocalyx thickening, because when monensin is removed the bacterial cells return to their original cellular morphology within a few generations.
Monensin adaptation is not a new phenomenon; in vitro cultures of rumen bacteria have previously been demonstrated to exhibit a long lag phase prior to growth in the presence of monensin. 20, 23 If the same culture is passaged again in monensincontaining medium, then the initial lag phase disappears and the cultures are said to be adapted. Adapted cultures can subsequently be shown to grow in high concentrations of monensin. 20 -25 In Clostridium aminophilum, adaptation is specific for monensin and bacitracin, another antibiotic active against the cell wall. It is important to emphasize that adapted cultures do not show cross-resistance with important antibiotics used in human medicine. 23 Callaway et al. 2 examined the potential issue of cross-resistance in respect to monensin adaptation in C. aminophilum F isolates. The authors postulated that monensin-adapted strains would have increased resistance to therapeutic antibiotics and they determined the MICs for monensin-adapted and monensin-susceptible isolates of 15 antibiotics, including ampicillin, cephalosporin C, vancomycin, tetracycline, erythromycin, lincomycin and bacitracin. The monensin-adapted isolates were in all but one case as susceptible as the monensin-wild-type isolates. The only antibiotic with a greater MIC value for the monensin-adapted isolates was bacitracin. The authors suggested that extracellular polysaccharides may contribute to bacitracin resistance in these isolates, as confirmed by Pollock et al. 30 A study by McConville et al. 31 using reference strains and contemporary testing methods showed there to be no increase in the monensin MIC for S. aureus, E. faecalis, C. perfringens or E. coli after 20 passages in the presence of monensin at MIC and sub-MIC concentrations. Neither was there any observed effect on the MIC of common classes of antibacterial agents.
Adaptation is a population-based phenomenon and does not imply that all of the individual bacterial members of the culture exhibit a resistant phenotype. Both adapted and non-adapted cultures consist of wild-type and non-wild-type cells, but in different proportions. Monensin-adapted cultures of C. aminophilum have been shown to contain 50-fold more monensin-adapted cells than non-adapted cultures. 25 The monensin-resistant subpopulations of Gram-negative bacterial cultures possess intrinsic outer membrane properties 22 and those of Gram-positive bacterial cultures have increased extracellular polysaccharide material. 25 Presumably, the changes to the outside of the bacteria confer adaptation, at least in part, by limiting access of monensin to the cell membrane. The data suggest that adaptation to monensin is actually a type of enrichment for those cells that are already present in the culture with cellular properties that are conducive to survival, such as those that produce more extracellular polysaccharides. These properties need not be the result of mutation or the acquisition of new genetic material because cell-to-cell phenotypic variation normally occurs amongst populations of otherwise genetically identical bacteria. Since some of the cells in a non-adapted culture inherently possess the ability to be monensin tolerant without prior selection by the ionophore, monensin adaptation can be considered a type of intrinsic property.
Four foodborne bacteria are considered to be especially important with respect to antibiotic resistance: the zoonotic pathogens Campylobacter and Salmonella and the commensal organisms E. coli and Enterococcus. Of these, only Enterococcus spp. has the potential to develop resistance in response to monensin. Campylobacter, Salmonella and E. coli are all intrinsically resistant to monensin. Many recent reports from European countries are focusing on salinomycin, as the ionophore class representative, rather than monensin as a means to assess ionophore resistance in E. faecium and/or E. faecalis. Salinomycin and monensin are both monovalent, polyether ionophores. The Danish Integrated Antimicrobial Resistance Monitoring and Research Programme (DANMAP) discontinued monensin testing in 1998 32 because there was no indication of resistance that posed a hazard to food safety or public health as a result of monensin use in animals. DANMAP subsequent to 1998 33, 34 replaced monensin with salinomycin as the ionophore class representative and has consistently shown 0% resistance to salinomycin in E. faecium and E. faecalis recovered from cattle using a breakpoint of 16 mg/L. In fact, in 2008 DANMAP 35 reduced the resistance breakpoint by a further dilution to 8 mg/L and still showed 0% resistance to salinomycin in E. faecium and E. faecalis recovered from cattle. Monitoring of Antimicrobial Resistance and Antibiotic Usage in Animals in the Netherlands ('MARAN'), on the other hand, has always used a breakpoint of 4 mg/L and, with the exception of E. faecium recovered from beef in 2004, 36 where the prevalence of resistance was reported to be 4.3%, have also reported 0% salinomycin resistance in enterococci of cattle origin. Only DANMAP in the European Union has reported on ionophore monitoring data in E. faecium and E. faecalis recovered from humans. These data clearly show that enterococci recovered from humans are not resistant to ionophores. In fact, in the USA the National Antimicrobial Resistance Monitoring System ('NARMS') Human Isolate report for 2004 37 indicated that 0% salinomycin-resistant enterococci were observed in 2003, so, as a result, in the 2004 report, daptomycin was used to replace salinomycin on the Enterococcus antibiotic panel. This indicates that there was no justification to continued testing of ionophores for potential resistance in either animals or human isolates-a strong indication of the microbiological food safety of ionophores. To our knowledge, there have not been any monensin resistance mechanisms or monensin resistance genes identified in enterococci.
The lack of monensin-resistant foodborne bacteria has two important implications. First, as there are no monensin-resistant strains of foodborne bacteria, there is no potential for crossresistant phenotypes. Second, as there are no known selectable monensin resistance genes, there is no possibility of the co-transfer of such genes and those conferring resistance to other types of antibiotics.
The theoretical risk that ionophores might induce resistance in bacteria that could spread to pathogenic species and strains and compromise the use of therapeutic antimicrobial compounds in humans is considered unlikely. Antimicrobials used in human and animal medicine act on bacteria in a limited number of ways. 38 For example: b-lactams and glycopeptides inhibit the synthesis of the bacterial cell wall; aminoglycosides, tetracyclines, macrolides and lincosamides inhibit protein synthesis; quinolones inhibit bacterial DNA replication; and sulphonamides inhibit folic acid metabolism. In each case the effectiveness of the antimicrobial depends upon specific interaction with the molecular target. Bacteria become resistant through mutation or acquisition of genes from other bacteria by plasmid transfer or other means.
The mode of action of monensin is more a biophysical phenomenon than a specific biochemical event. The fundamental antimicrobial activity of monensin is a result of rendering the single lipid bilayer barrier ineffective for preserving balanced monovalent cation diffusion. This effect is due to innate physicochemical and biophysical properties, unlike antimicrobial compounds that have a specific biochemical target such as an enzyme, ribosome or transport protein. This fact alone sets monensin apart from virtually all other antimicrobial agents. Both structurally and in terms of its mode of action and mechanism of resistance, monensin is unlike other antimicrobial compounds currently approved for use in human medicine. Increased tolerance to monensin is almost certainly a polygenic event, which may provide a continuum of degrees of tolerance. The nonspecific biophysical nature of the ionophore mode of action would require a profound change in bacterial cell wall and membrane structure to be overcome, likely requiring multiple gene mutations for resistance to develop. The number and size of the genes necessary to accomplish such a massive reordering of these components would be so large as to preclude an effective gene exchange. It is highly unlikely that the magnitude of genetic information necessary to afford any substantial degree of tolerance to monensin could be contained on a bacterial plasmid. In fact, it has been reported that bacterial resistance to ionophores would be chromosomal and not plasmidencoded. 39 Thus, transference of bacterial resistance via plasmid exchange is highly unlikely. This is consistent with the view that the risk of the development of bacterial crossresistance that poses a risk to humans is non-existent.
Monensin adaptation has been described as 'physiological resistance' or 'phenotypic selection', 2, 40 though precisely what these terms mean has not been fully developed. It is suggested that the monensin resistance observed in some types of ruminal bacteria is really a type of non-inheritable antibiotic resistance. The above studies have determined the reversible changes that take place at a cellular level.
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